MUMBAI, India, Feb. 21 -- Intellectual Property India has published a patent application (202321055539 A) filed by Alembic Pharmaceuticals Limited, Vadodara, Gujarat, on Aug. 18, 2023, for 'polymorph of ribociclib salt.'
Inventor(s) include Kumar, Ramesh; Tomer, Sanjiv; Kanzariya, Kamlesh; and Patel, Vaibhav.
The application for the patent was published on Feb. 21, under issue no. 08/2025.
According to the abstract released by the Intellectual Property India: "The invention relates to polymorph of Ribociclib citrate salt and pharmaceutical compositions thereof. The present invention also relates to preparation method thereof. In particular, the invention relates to Ribociclib citrate dihydrate."
Disclaimer: Curated by HT Syndication....